NCT02359188View on ClinicalTrials.gov

Transcutaneous Vagal Nerve Stimulation: Influence on miRNA, Inflammation, Cerebral Resting State and Gastric Motility

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Epilepsy
Interventions
DEVICE

Transcutaneous vagal nerve stimulation

4 hours of transcutaneous vagal nerve stimulation

Trial Locations (1)

35043

Philipps-University Marburg, Dept. of Neurology, Epilepsy Center Hesse-Marburg, Marburg

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Philipps University Marburg

OTHER

NCT02359188 - Transcutaneous Vagal Nerve Stimulation: Influence on miRNA, Inflammation, Cerebral Resting State and Gastric Motility | Biotech Hunter | Biotech Hunter